These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16193872)

  • 1. [Topical immunomodulator against skin cancer. Does the cream replace the knife? (interview by Dr. Judith Neumaier)].
    Hauschild A
    MMW Fortschr Med; 2005 Sep; 147(37):21. PubMed ID: 16193872
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonsurgical therapy holds promise for basal cell carcinoma.
    Oncology (Williston Park); 1999 Jul; 13(7):1044. PubMed ID: 10442350
    [No Abstract]   [Full Text] [Related]  

  • 3. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
    Akkilic-Materna M; Massone C; Komericki P
    Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of basal cell carcinoma with the immune response modifier imiquimod.
    Papakostas D; Stockfleth E
    Future Oncol; 2015 Nov; 11(22):2985-90. PubMed ID: 26450707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial success with topical immunomodulators. A creme for skin cancer? (interview by Renate Jackle)].
    Hengge U
    MMW Fortschr Med; 2001 May; 143(21):11. PubMed ID: 11420824
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of imiquimod in skin cancer treatment.
    Urosevic M; Dummer R
    Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cream to treat skin cancer? [news].
    Mayo Clin Health Lett; 2001 Mar; 19(3):4. PubMed ID: 11242841
    [No Abstract]   [Full Text] [Related]  

  • 8. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P; Monsieur E; Petein M; Heenen M
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: "Imiquimod 5% cream for the treatment of periocular basal cell carcinoma".
    Pakdel F; Kashkouli MB
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):305; author reply 305-6. PubMed ID: 20966793
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Rub on' treatment for basal-cell carcinoma.
    Kerr C
    Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimizing surgery in skin cancer treatment. A new test looks for cancer in the lymph nodes during melanoma surgery, while a topical cream helps people with another form of skin cancer avoid the knife.
    Health News; 2005 Feb; 11(2):12-3. PubMed ID: 15732154
    [No Abstract]   [Full Text] [Related]  

  • 15. Cream to be tested as skin cancer care.
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):621. PubMed ID: 12503207
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.
    Hannuksela-Svahn A; Nordal E; Christensen OB
    Acta Derm Venereol; 2000; 80(5):381-2. PubMed ID: 11200841
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
    Harting M; Vujevich J; Goldberg LH
    Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe.
    Gollnick H; Barona CG; Frank RG; Ruzicka T; Megahed M; Tebbs V; Owens M; Stampone P
    Eur J Dermatol; 2005; 15(5):374-81. PubMed ID: 16172048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant treatment with topical 5% imiquimod cream for resected stage IIIb melanoma.
    Tiodorovic-Zivkovic D; Argenziano G; Catricalà C; Ferrara G; Giorgio CM; Moscarella E; Zalaudek I
    Eur J Dermatol; 2011; 21(3):410-1. PubMed ID: 21515443
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma: A Randomized Clinical Trial.
    Kessels J; Voeten L; Nelemans P; Cleutjens J; Hillen LM; Mosterd K; Kelleners-Smeets NWJ
    JAMA Dermatol; 2017 Oct; 153(10):1061-1063. PubMed ID: 28793140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.